Reimbursement Scheme Forxiga® (dapagliflozine) 10 mg - Chronic Kidney Disease
The health insurer does not yet fully reimburse Forxiga® (dapagliflozine) 10 mg for the treatment of chronic kidney disease (CKD). The manufacturer of this medicine has therefore asked TBR Nederland to reimburse the total costs of the Personal Contribution to the patient.
The Personal Contribution for Forxiga® (dapagliflozine) 10 mg that is charged to the patient by the pharmacy will be fully reimbursed from August 5 2021.
Who can submit a claim
Only patients or their caregivers can claim the Personal Contribution Forxiga® (dapagliflozine) 10 mg online or by post. Online will be the fastest option. Pharmacists can also claim this medicine on behalf of the patient. This can only be submitted online.